Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

A man with severe hair loss regrew hair after hormone treatment.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Alopecia areata affects 1.45% of people in Japan, impacting mood and self-esteem, with many not seeking treatment.

Alopecia areata negatively affects the self-esteem and quality of life of children and teens.

Nivolumab can cause hair loss as a rare side effect.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Children with atopic diseases have a higher risk of developing alopecia areata.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Alopecia Areata affects young adults more in high-income countries, especially females.

Addressing alexithymia can improve anxiety and depression in alopecia areata patients.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Alopecia areata may be linked to higher heart disease risk.

ITK inhibitors may effectively treat alopecia areata.

A young girl with skin and scalp conditions showed some improvement with treatment.

A specific gene variant may increase the risk of developing Alopecia Areata.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Baricitinib shows promise for treating alopecia areata with mild side effects.